Blood Neurofilament Light Chain Levels and Association with Brain Volume Change in Patients with Primary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis Before and During Ocrelizumab Treatment

被引：0

作者：

Jia, Xiaoming ^{[1
]}

Herman, Ann ^{[1
]}

Harp, Christopher ^{[1
]}

Cross, Anne ^{[2
]}

Fiore, Damian ^{[1
]}

Hauser, Stephen ^{[3
]}

Kappos, Ludwig ^{[4
]}

Koendgen, Harold ^{[5
]}

Kuhle, Jens ^{[4
]}

Leppert, David ^{[4
]}

Manfrini, Marianna ^{[5
]}

Model, Fabian ^{[5
]}

Oksenberg, Jorge ^{[3
]}

Sauter, Annette ^{[5
]}

Thanei, Gian-Andrea ^{[5
]}

Bar-Or, Amit ^{[6
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

[2] Washington Univ, Sch Med, St Louis, MO 14263 USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Univ Hosp Basel, Basel, Switzerland

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

NEUROLOGY | 2020年 / 94卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

3926

引用

页数：4

共 50 条

[11] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Guittari, Carol-Jean
Koendgen, Harold
Li, Carrie
Marcillat, Carole
Wormser, David
Wolinsky, Jerry
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
[12] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Hughes, R.
McNamara, J.
Pradhan, A.
Wormser, D.
Koendgen, H.
Wolinsky, J. S.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
[13] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, Stephen
Kappos, Ludwig
Montalban, Xavier
Chognot, Cathy
Jessop, Nikki
Kadner, Karen
Pradhan, Ashish
Incera, Elodie
Wolinsky, Jerry
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
[14] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S.
Kappos, L.
Montalban, X.
Chognot, C.
Craveiro, L.
Pradhan, A.
Prajapati, K.
Wolinsky, J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306
[15] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Chognot, C.
Jessop, N.
Kadner, K.
Pradhan, A.
Prajapati, K.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 354 - 355
[16] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Hughes, Richard
McNamara, John
Pradhan, Ashish
Wormser, David
Koendgen, Harold
Wolinsky, Jerry S.
NEUROLOGY, 2019, 92 (15)
[17] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Hughes, R.
Koendgen, H.
McNamara, J.
Pradhan, A.
Wormser, D.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
[18] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Chognot, C.
Jessop, N.
Pradhan, A.
Prajapati, K.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
[19] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Prajapati, K.
Koendgen, H.
Craveiro, L.
Hughes, R.
Pradhan, A.
Wolinsky, J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 68 - 69
[20] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Koendgen, H.
Li, C.
Marcillat, C.
Pradhan, A.
Wormser, D.
Wolinsky, J. S.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 334 - 334

← 1 2 3 4 5 →